Breaking News Instant updates and real-time market news.

QCOM

Qualcomm

$57.05

-1.07 (-1.84%)

, JNJ

Johnson & Johnson

$131.53

0.98 (0.75%)

07:31
06/12/17
06/12
07:31
06/12/17
07:31

Qualcomm announces agreement with LifeScan

Qualcomm (QCOM), through its subsidiary Qualcomm Life, announced its agreement with LifeScan, one of the Johnson & Johnson (JNJ) Diabetes Care Companies, to streamline wireless data capture from LifeScan's OneTouch Verio Flex blood glucose meters to physicians to enable more informed care. Qualcomm Life's medical-grade 2net solution will power the connectivity for efficient, cable-free data collection. The companies plan to deploy the 2net solution to select physician offices in the Fall of 2017, and expand globally in 2018.

QCOM

Qualcomm

$57.05

-1.07 (-1.84%)

JNJ

Johnson & Johnson

$131.53

0.98 (0.75%)

  • 13

    Jun

  • 15

    Jun

QCOM Qualcomm
$57.05

-1.07 (-1.84%)

05/22/17
JPMS
05/22/17
UPGRADE
Target $68
JPMS
Overweight
Qualcomm upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Rod Hall upgraded Qualcomm (QCOM) to Overweight and raised his price target for the shares to $68 from $50. The chipmaker closed Friday up $1.55 to $57.67. While more negative news from the Apple (AAPL) royalty suit is likely, "material fundamental upside" exists from the closure of the NXP Semiconductors (NXPI) by the end of this year, Hall tells investors in a research note. The analyst views the deal as highly accretive. Hall also believes Apple ultimately will want to preserve its commercial relationship with Qualcomm.
05/22/17
05/22/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Overweight from Neutral at JPMorgan with analyst Rod Hall saying while more negative news from the Apple (AAPL) royalty suit is likely, "material fundamental upside" exists from the closure of the NXP Semiconductors (NXPI) by the end of this year. The analyst views the deal as highly accretive. Hall also believes Apple ultimately will want to preserve its commercial relationship with Qualcomm. 2. Motorola Solutions (MSI) upgraded to Outperform from Market Perform at Raymond James with analyst Tavis McCourt saying shares look increasingly attractive based on improved demand visibility that is less economically sensitive than many of its peers, and demand catalysts from FirstNet buildouts that are expected to start in 2018. 3. Entegris (ENTG) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Toshiya Hari citing the recent pullback in shares and maintained a $29 price target. 4. Blackstone (BX) upgraded to Buy from Neutral at Citi with analyst William Katz saying the company's intentions to raise a $40B infrastructure fund should be a "valuation catalyst." 5. Cree (CREE) upgraded to Outperform from Market Perform at JMP Securities with analyst Joseph Osha saying he thinks that the company's new CEO could make positive changes at the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/26/17
STFL
05/26/17
NO CHANGE
STFL
Qualcomm price target raised to $65 from $56 at Stifel
Stifel analyst Kevin Cassidy raised his price target on Qualcomm (QCOM) as he believes that the company's application processors are gaining share in smartphones. The analyst says that the settlement between Apple (AAPL) and Nokia (NOK) is encouraging for Qualcomm, given its own legal dispute with Apple. The analyst keeps a Buy rating on Qualcomm.
05/29/17
RAJA
05/29/17
DOWNGRADE
Target $11
RAJA
Market Perform
BlackBerry downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst Steven Li downgraded BlackBerry (BBRY) to Market Perform while raising his price target for the shares to $11 from $9.50. The mobile communications solutions provider closed Friday down 11c to $11.11. The shares are up 42% since the analyst's upgrade to Outperform on August 12, 2016. The final award payment of $940M by Qualcomm (QCOM) boosts an "already strong balance sheet" and may be used for acquisitions, Li tells investors in a research not titled "Tapping the Brakes after Strong Run."
JNJ Johnson & Johnson
$131.53

0.98 (0.75%)

06/05/17
PIPR
06/05/17
NO CHANGE
PIPR
Piper views AstraZeneca, J&J as ASCO standouts
The standouts at ASCO over the weekend were the "compelling results" presented on Johnson & Johnson's (JNJ) Zytiga from the Latitude study in prostate cancer and AstraZeneca's (AZN) Lynparza in the OlympiAD trial in BRCA mutant breast cancer, Piper Jaffray analyst Richard Purkiss tells investors in a research note. In lung cancer, Merck's (MRK) updated data in KN021G "appears more promising" than Bristol-Myers' (BMY) updated data in CM012, the analyst adds. Purkiss believes, however, that relative to recent ASCOs, the data "so far in totality is underwhelming."
06/06/17
WELS
06/06/17
NO CHANGE
WELS
Amazon may be the next threat to drug pricing, says Wells Fargo
After CNBC recently reported that Amazon (AMZN) is considering going into the prescription pharmacy business in the U.S., Wells Fargo surveyed nearly 2,900 U.S. adults and found that 54% of those polled said they would use or would probably use "Amazon Pharmacy." While the e-commerce giant has not confirmed its U.S. pharmacy interest, if it did enter the market analyst David Maris believes it could see fast adoption and "usher in a new age of price transparency." Maris also wonders if pharmacy "may be just the beginning" and if Amazon eyes the "even larger prize" of fully integrated digital healthcare. Publicly traded large-cap pharmaceuticals companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded retail pharmacy operators include CVS Health (CVS), Walgreens (WBA), Fred's (FRED) and Rite Aid (RAD).
06/07/17
FBCO
06/07/17
NO CHANGE
Target $38
FBCO
Outperform
ASCO meeting highlights pressure on Pfizer cancer assets, says Credit Suisse
Credit Suisse analyst Vamil Divan said he came away from the ASCO meeting feeling like positive progress by competitors is increasing the pressure on Pfizer's (PFE) cancer assets, specifically pointing to positive data for Roche's (RHHBY) Alecensa, Johnson & Johnson's (JNJ) Zytiga and Eli Lilly's (LLY) abemaciclib. Additionally, competition in the immune-oncology and PARP spaces will make it more challenging for Pfizer to gain traction, added Divan. He keeps an Outperform rating on Pfizer, citing valuation and its dividend yield, but he has concerns about its upcoming patent expirations and growth products.
06/09/17
FBCO
06/09/17
NO CHANGE
FBCO
Outperform
Tesaro prostate study suspension due to fast enrollment, says Credit Suisse
After speaking to Tesaro (TSRO), after they spoke to their partner Johnson & Johnson (JNJ), Credit Suisse analyst Alethia Young said the news of the companies' suspension of participant recruitment in the study of niraparib in prostate cancer is actually positive, since it is due to the trial enrolling faster than expected. The suspension has nothing to do with safety or efficacy and is not a clinical hold, but is due to having too many patients in the first part of trial, Young was told. She maintains an Outperform rating on Tesaro shares.

TODAY'S FREE FLY STORIES

CO

China Cord Blood

$12.49

0.18 (1.46%)

06:45
08/24/17
08/24
06:45
08/24/17
06:45
Technical Analysis
Technical View: China Cord Blood hits new highs in pre-market »

Shares were last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

TIF

Tiffany

$88.72

0.22 (0.25%)

06:44
08/24/17
08/24
06:44
08/24/17
06:44
Hot Stocks
Tiffany provides FY17 outlook »

Management's outlook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

TIF

Tiffany

$88.72

0.22 (0.25%)

06:43
08/24/17
08/24
06:43
08/24/17
06:43
Hot Stocks
Tiffany sees FY17 CapEx $250M »

Sees FY17 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

TIF

Tiffany

$88.72

0.22 (0.25%)

06:42
08/24/17
08/24
06:42
08/24/17
06:42
Earnings
Tiffany sees FY17 EPS growth of high single digits, consensus $3.95 »

Sees FY17 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

TIF

Tiffany

$88.72

0.22 (0.25%)

06:40
08/24/17
08/24
06:40
08/24/17
06:40
Earnings
Tiffany reports Q2 adjusted EPS 92c, consensus 86c »

Reports Q2 revenue $960M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

HMLP

Hoegh LNG

$18.60

0.25 (1.36%)

06:38
08/24/17
08/24
06:38
08/24/17
06:38
Earnings
Hoegh LNG reports Q2 EPS 28c, consensus 40c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 12

    Sep

WDC

Western Digital

$88.31

1.66 (1.92%)

, TOSYY

Toshiba, also use TOSBF

$17.28

0.49 (2.92%)

06:38
08/24/17
08/24
06:38
08/24/17
06:38
Periodicals
Western Digital consortium to offer $17.4B for Toshiba chip unit, Reuters says »

A consortium that…

WDC

Western Digital

$88.31

1.66 (1.92%)

TOSYY

Toshiba, also use TOSBF

$17.28

0.49 (2.92%)

TOSBF

Toshiba, also use TOSYY

$2.88

0.064 (2.27%)

KKR

KKR

$18.57

-0.07 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXC

Exelon

$38.32

0.09 (0.24%)

06:36
08/24/17
08/24
06:36
08/24/17
06:36
Conference/Events
Exelon management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

06:35
08/24/17
08/24
06:35
08/24/17
06:35
General news
FX Action: USD-JPY has settled in the lower 109.0s »

FX Action: USD-JPY has…

DXLG

Destination XL

06:34
08/24/17
08/24
06:34
08/24/17
06:34
Conference/Events
Destination XL management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 31

    Aug

  • 28

    Sep

BDC

Belden

$73.25

0.08 (0.11%)

06:34
08/24/17
08/24
06:34
08/24/17
06:34
Conference/Events
Belden management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

  • 06

    Sep

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:33
08/24/17
08/24
06:33
08/24/17
06:33
Hot Stocks
Hormel Foods acquires Ceratti brand for approximately $104M »

Hormel Foods announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:33
08/24/17
08/24
06:33
08/24/17
06:33
Earnings
Hormel cuts FY EPS view to $1.54-$1.58 from low end of $1.65-$1.71 »

Consensus is $1.65.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:32
08/24/17
08/24
06:32
08/24/17
06:32
Hot Stocks
Hormel Foods says faced 'record-high' input costs for two primary raw materials »

"We generated record…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

AVD

American Vanguard

$20.00

0.15 (0.76%)

06:32
08/24/17
08/24
06:32
08/24/17
06:32
Conference/Events
American Vanguard management to meet with Oppenheimer »

Meeting to be held in St.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Earnings
Hormel Foods reports Q3 EPS 34c, consensus 37c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

WBC

Wabco

$138.46

0.22 (0.16%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Hot Stocks
Wabco to acquire Sheppard for $145M »

WABCO announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Sep

AIN

Albany International

$51.10

-0.2 (-0.39%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Conference/Events
Albany International management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

  • 01

    Sep

  • 28

    Sep

EADSY

Airbus

$20.89

-0.015 (-0.07%)

, DLAKY

Lufthansa

$24.60

-0.04 (-0.16%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Periodicals
European regulator, Airbus issue software fix for A350, Reuters reports »

The European Aviation…

EADSY

Airbus

$20.89

-0.015 (-0.07%)

DLAKY

Lufthansa

$24.60

-0.04 (-0.16%)

SINGY

Singapore Airlines

CPCAY

Cathay Pacific

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTD

L Brands

06:30
08/24/17
08/24
06:30
08/24/17
06:30
Conference/Events
L Brands to host sales conference call »

Pre-Recorded August sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

06:30
08/24/17
08/24
06:30
08/24/17
06:30
General news
FX Action: USD-JPY has settled in the lower 109.0s »

FX Action: USD-JPY has…

BRCD

Brocade

$12.25

0.06 (0.49%)

, AVGO

Broadcom

$256.92

1.73 (0.68%)

06:22
08/24/17
08/24
06:22
08/24/17
06:22
Hot Stocks
China conditionally approves Broadcom's proposed acquisition of Brocade »

In a regulatory filing,…

BRCD

Brocade

$12.25

0.06 (0.49%)

AVGO

Broadcom

$256.92

1.73 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 24

    Aug

FB

Facebook

$168.71

-0.93 (-0.55%)

06:20
08/24/17
08/24
06:20
08/24/17
06:20
Periodicals
Facebook taps exec Andrew Bosworth to lead hardware efforts, BI reports »

Facebook has selected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 13

    Sep

GOOG

Alphabet

$927.00

2.31 (0.25%)

, GOOGL

Alphabet Class A

$942.58

2.18 (0.23%)

06:20
08/24/17
08/24
06:20
08/24/17
06:20
Periodicals
Google could unveil new Pixel phones on October 5, Engadget reports »

Google (GOOG) could…

GOOG

Alphabet

$927.00

2.31 (0.25%)

GOOGL

Alphabet Class A

$942.58

2.18 (0.23%)

QCOM

Qualcomm

$52.23

-0.12 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

NADL

North Atlantic Drilling

$1.19

0.02 (1.71%)

06:17
08/24/17
08/24
06:17
08/24/17
06:17
Earnings
North Atlantic Drilling reports Q2 EPS ($2.59), consensus ($2.97) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.